| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |